{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Fumonisines : Questions médicales les plus fréquentes",
"headline": "Fumonisines : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Fumonisines : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-17",
"dateModified": "2025-02-11",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Fumonisines"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Mycotoxines",
"url": "https://questionsmedicales.fr/mesh/D009183",
"about": {
"@type": "MedicalCondition",
"name": "Mycotoxines",
"code": {
"@type": "MedicalCode",
"code": "D009183",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.946.587"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Fumonisines",
"alternateName": "Fumonisins",
"code": {
"@type": "MedicalCode",
"code": "D037341",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "András Szabó",
"url": "https://questionsmedicales.fr/author/Andr%C3%A1s%20Szab%C3%B3",
"affiliation": {
"@type": "Organization",
"name": "MTA-KE-SZIE Mycotoxins in the Food Chain Research Group, Kaposvár University, Kaposvár, Hungary."
}
},
{
"@type": "Person",
"name": "Melinda Kovács",
"url": "https://questionsmedicales.fr/author/Melinda%20Kov%C3%A1cs",
"affiliation": {
"@type": "Organization",
"name": "MTA-KE-SZIE Mycotoxins in the Food Chain Research Group, Kaposvár University, Kaposvár, Hungary."
}
},
{
"@type": "Person",
"name": "Naeem Sheik Abdul",
"url": "https://questionsmedicales.fr/author/Naeem%20Sheik%20Abdul",
"affiliation": {
"@type": "Organization",
"name": "Discipline of Medical Biochemistry, School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, 4041, South Africa; Applied Microbial and Health Biotechnology Institute, Cape Peninsula University of Technology, Cape Town, 7535, South Africa."
}
},
{
"@type": "Person",
"name": "Anil A Chuturgoon",
"url": "https://questionsmedicales.fr/author/Anil%20A%20Chuturgoon",
"affiliation": {
"@type": "Organization",
"name": "Discipline of Medical Biochemistry, School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, 4041, South Africa. Electronic address: chutur@ukzn.ac.za."
}
},
{
"@type": "Person",
"name": "Terisha Ghazi",
"url": "https://questionsmedicales.fr/author/Terisha%20Ghazi",
"affiliation": {
"@type": "Organization",
"name": "Discipline of Medical Biochemistry, School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban 4041, South Africa."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Long noncoding RNA profile of the intracranial artery in patients with moyamoya disease.",
"datePublished": "2022-07-29",
"url": "https://questionsmedicales.fr/article/35907193",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3171/2022.5.JNS22579"
}
},
{
"@type": "ScholarlyArticle",
"name": "Characterization of the long noncoding RNA transcriptome in human preimplantation embryo development.",
"datePublished": "2023-09-29",
"url": "https://questionsmedicales.fr/article/37770818",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10815-023-02951-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "Association of Circulating Long Noncoding 7S RNA with Deep Vein Thrombosis.",
"datePublished": "2023-08-23",
"url": "https://questionsmedicales.fr/article/37611624",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1055/s-0043-1772705"
}
},
{
"@type": "ScholarlyArticle",
"name": "The long intergenic noncoding RNA ARES modulates root architecture in Arabidopsis.",
"datePublished": "2023-07-06",
"url": "https://questionsmedicales.fr/article/37409758",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/iub.2761"
}
},
{
"@type": "ScholarlyArticle",
"name": "Long Noncoding RNA UCA1 Correlates With Electropathology in Patients With Atrial Fibrillation.",
"datePublished": "2023-05-24",
"url": "https://questionsmedicales.fr/article/37227342",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jacep.2023.02.018"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Facteurs biologiques",
"item": "https://questionsmedicales.fr/mesh/D001685"
},
{
"@type": "ListItem",
"position": 3,
"name": "Toxines biologiques",
"item": "https://questionsmedicales.fr/mesh/D014118"
},
{
"@type": "ListItem",
"position": 4,
"name": "Mycotoxines",
"item": "https://questionsmedicales.fr/mesh/D009183"
},
{
"@type": "ListItem",
"position": 5,
"name": "Fumonisines",
"item": "https://questionsmedicales.fr/mesh/D037341"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Fumonisines - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Fumonisines",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-04",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Fumonisines",
"description": "Comment diagnostiquer une intoxication par fumonisines ?\nQuels tests sont utilisés pour détecter les fumonisines ?\nQuels symptômes indiquent une intoxication par fumonisines ?\nPeut-on détecter les fumonisines dans le sang ?\nLes tests de laboratoire sont-ils fiables pour les fumonisines ?",
"url": "https://questionsmedicales.fr/mesh/D037341?mesh_terms=RNA,+Long+Noncoding&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Fumonisines",
"description": "Quels sont les symptômes d'une exposition aiguë aux fumonisines ?\nLes fumonisines causent-elles des effets neurologiques ?\nY a-t-il des symptômes à long terme liés aux fumonisines ?\nLes symptômes varient-ils selon l'âge ?\nLes symptômes sont-ils immédiats après exposition ?",
"url": "https://questionsmedicales.fr/mesh/D037341?mesh_terms=RNA,+Long+Noncoding&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Fumonisines",
"description": "Comment prévenir l'exposition aux fumonisines ?\nLes contrôles alimentaires sont-ils efficaces contre les fumonisines ?\nQuelles pratiques agricoles aident à prévenir les fumonisines ?\nLes fumonisines peuvent-elles être éliminées par la cuisson ?\nLes tests de détection sont-ils recommandés pour les aliments ?",
"url": "https://questionsmedicales.fr/mesh/D037341?mesh_terms=RNA,+Long+Noncoding&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Fumonisines",
"description": "Quel traitement est recommandé pour l'intoxication par fumonisines ?\nDes antidotes existent-ils pour les fumonisines ?\nComment gérer les symptômes gastro-intestinaux ?\nLes traitements varient-ils selon la gravité de l'intoxication ?\nFaut-il hospitaliser les patients exposés aux fumonisines ?",
"url": "https://questionsmedicales.fr/mesh/D037341?mesh_terms=RNA,+Long+Noncoding&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Fumonisines",
"description": "Quelles sont les complications possibles d'une intoxication par fumonisines ?\nLes fumonisines peuvent-elles affecter le foie ?\nY a-t-il un risque accru de cancer avec les fumonisines ?\nLes fumonisines peuvent-elles causer des problèmes respiratoires ?\nLes complications sont-elles réversibles ?",
"url": "https://questionsmedicales.fr/mesh/D037341?mesh_terms=RNA,+Long+Noncoding&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Fumonisines",
"description": "Quels sont les principaux facteurs de risque d'exposition aux fumonisines ?\nLes personnes immunodéprimées sont-elles plus à risque ?\nLe climat influence-t-il la présence de fumonisines ?\nLes enfants sont-ils plus à risque d'intoxication ?\nLes travailleurs agricoles sont-ils exposés aux fumonisines ?",
"url": "https://questionsmedicales.fr/mesh/D037341?mesh_terms=RNA,+Long+Noncoding&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une intoxication par fumonisines ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'analyse des échantillons alimentaires et des tests biologiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour détecter les fumonisines ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests chromatographiques comme la HPLC sont couramment utilisés pour détecter les fumonisines."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une intoxication par fumonisines ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des douleurs abdominales, des nausées et des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Peut-on détecter les fumonisines dans le sang ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des analyses sanguines peuvent révéler la présence de fumonisines dans l'organisme."
}
},
{
"@type": "Question",
"name": "Les tests de laboratoire sont-ils fiables pour les fumonisines ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les tests de laboratoire sont généralement fiables pour détecter les fumonisines."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une exposition aiguë aux fumonisines ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes aigus incluent des vomissements, des douleurs abdominales et des diarrhées."
}
},
{
"@type": "Question",
"name": "Les fumonisines causent-elles des effets neurologiques ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition aux fumonisines peut entraîner des troubles neurologiques et cognitifs."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes à long terme liés aux fumonisines ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une exposition prolongée peut augmenter le risque de cancers et de maladies chroniques."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les enfants peuvent être plus sensibles aux effets des fumonisines que les adultes."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils immédiats après exposition ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pas toujours, certains symptômes peuvent apparaître plusieurs heures après l'exposition."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'exposition aux fumonisines ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évitez les aliments contaminés et stockez les céréales dans des conditions appropriées."
}
},
{
"@type": "Question",
"name": "Les contrôles alimentaires sont-ils efficaces contre les fumonisines ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des contrôles réguliers des aliments peuvent réduire le risque d'exposition."
}
},
{
"@type": "Question",
"name": "Quelles pratiques agricoles aident à prévenir les fumonisines ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "La rotation des cultures et le contrôle de l'humidité peuvent aider à prévenir leur apparition."
}
},
{
"@type": "Question",
"name": "Les fumonisines peuvent-elles être éliminées par la cuisson ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "La cuisson ne détruit pas les fumonisines, il est donc crucial de prévenir leur contamination."
}
},
{
"@type": "Question",
"name": "Les tests de détection sont-ils recommandés pour les aliments ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests de détection réguliers sont recommandés pour assurer la sécurité alimentaire."
}
},
{
"@type": "Question",
"name": "Quel traitement est recommandé pour l'intoxication par fumonisines ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement consiste principalement en des soins de soutien et une hydratation adéquate."
}
},
{
"@type": "Question",
"name": "Des antidotes existent-ils pour les fumonisines ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas d'antidote spécifique pour les intoxications par fumonisines."
}
},
{
"@type": "Question",
"name": "Comment gérer les symptômes gastro-intestinaux ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments antiémétiques et des solutions de réhydratation peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "Les traitements varient-ils selon la gravité de l'intoxication ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements peuvent être plus intensifs en cas d'intoxication sévère."
}
},
{
"@type": "Question",
"name": "Faut-il hospitaliser les patients exposés aux fumonisines ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hospitalisation peut être nécessaire pour les cas graves ou les complications."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles d'une intoxication par fumonisines ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des troubles neurologiques, des cancers et des maladies chroniques."
}
},
{
"@type": "Question",
"name": "Les fumonisines peuvent-elles affecter le foie ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition aux fumonisines peut entraîner des lésions hépatiques et des dysfonctionnements."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque accru de cancer avec les fumonisines ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des études montrent un lien entre l'exposition aux fumonisines et certains cancers."
}
},
{
"@type": "Question",
"name": "Les fumonisines peuvent-elles causer des problèmes respiratoires ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études suggèrent que l'exposition prolongée peut entraîner des problèmes respiratoires."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles, mais d'autres peuvent être permanentes."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque d'exposition aux fumonisines ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les principaux facteurs incluent la consommation de maïs contaminé et le stockage inadéquat."
}
},
{
"@type": "Question",
"name": "Les personnes immunodéprimées sont-elles plus à risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes immunodéprimées peuvent être plus vulnérables aux effets des fumonisines."
}
},
{
"@type": "Question",
"name": "Le climat influence-t-il la présence de fumonisines ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des conditions climatiques humides favorisent la croissance des champignons producteurs de fumonisines."
}
},
{
"@type": "Question",
"name": "Les enfants sont-ils plus à risque d'intoxication ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les enfants sont plus sensibles aux effets toxiques des fumonisines en raison de leur métabolisme."
}
},
{
"@type": "Question",
"name": "Les travailleurs agricoles sont-ils exposés aux fumonisines ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les travailleurs agricoles peuvent être exposés lors de la manipulation de cultures contaminées."
}
}
]
}
]
}
Moyamoya disease (MMD) is a rare cerebrovascular disease characterized by progressive stenosis of the internal carotid artery (ICA) and secondary formation of collateral vessels. Revascularization sur...
The authors collected microsamples of the middle cerebral artery (MCA) from patients with MMD (n = 21) and patients with control conditions (n = 11) who underwent neurosurgical treatment. Using microa...
The authors detected 308 differentially expressed lncRNAs (fold change > 2, q < 0.05), including 306 upregulated and 2 downregulated lncRNAs in the MCA from patients with MMD. Regarding the prediction...
The profile of lncRNA expression in MMD lesions was different from that in the normal cerebral artery, and differentially expressed lncRNAs were identified. This study provides new insights into the p...
Infertility remains a human health burden globally. Only a fraction of embryos produced via assisted reproductive technologies (ARTs) develop to the blastocyst stage in vitro. lncRNA abundance changes...
scRNA-seq data and SUPeR-seq data were used to investigate the lncRNA profiles of human preimplantation embryos. The top 50 highly expressed unique and shared lncRNAs in each stage of preimplantation ...
The lncRNA profiles of human preimplantation embryos in the E-MTAB-3929 dataset were similar to those in the GSE71318 dataset. The ratios of overlap among the top 50 highly expressed lncRNAs between t...
Our study paves the way for understanding the regulation of developmental events, which might be beneficial for improved reproductive outcomes....
Mitochondrial dysfunction is a recognized factor in the pathogenesis of deep vein thrombosis (DVT). The role of 7S RNA, a long noncoding RNA that plays an important role in mitochondrial function, in ...
Long noncoding RNAs (lncRNAs) have emerged as important regulators of gene expression in plants. They have been linked to a wide range of molecular mechanisms, including epigenetics, miRNA activity, R...
Perpetuation of atrial fibrillation (AF) is rooted in derailment of molecular proteostasis pathways that cause electrical conduction disorders that drive AF. Emerging evidence indicates a role for lon...
In the present study, the authors explored the association between 3 cardiac lncRNAs and the degree of electropathology....
Patients had paroxysmal AF (ParAF) (n = 59), persistent AF (PerAF) (n = 56), or normal sinus rhythm without a history of AF (SR) (n = 70). The relative expression levels of urothelial carcinoma-associ...
The expression levels of SARRAH and LIPCAR were decreased in RAAs of all AF patients compared with SR. Also, in RAAs, UCA1 levels significantly correlated with the percentage of conduction block and d...
LncRNAs SARRAH and LIPCAR are reduced in RAA of AF patients, and UCA1 levels correlate with electrophysiologic conduction abnormalities. Thus, RAA UCA1 levels may aid staging of electropathology sever...
Long non coding RNAs (lncRNAs) are involved in the tumor growth, invasion, metastasis, and cancer recurrence. The improper expression of certain lncRNAs is correlated with the prognosis of the cancer ...
Renal cell carcinoma is one of the common cancers whose incidence and mortality are continuously growing worldwide. Initially, this type of tumour is usually asymptomatic. Due to the lack of reliable ...
Parkinson's disease (PD) is a neurodegenerative disease resulted from the loss of dopaminergic neurons. Here, we analyzed the role of long noncoding RNA (lncRNA) small nucleolar RNA host gene 14 (SNHG...
Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) and Western blot assay were performed to determine RNA and protein expression, respectively. 3-(4,5-Dimethylthiazol-2-yl)-2,5-dip...
MPP...
SNHG14 promoted MPP...
Hepatocellular carcinoma (HCC) and pancreatic cancer (PC) are among serious malignancies with no proper biomarker suffering from poor prognosis and late onset. Regulation of long noncoding RNAs (lncRN...
Tumor necrosis factor-α (TNF-α) and heterogenous nuclear ribonucleoprotein L (hnRNPL)-related immunoregulatory lincRNA (THRIL) is a long noncoding RNA (lncRNA) involved in various inflammatory disease...